NYSE$EHAB

Enhabit Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

Enhabit reported Q1 2025 net income of $18.4M, diluted EPS of $0.35.

For Q1 2025, Enhabit reported net income was $18.4M, diluted EPS was $0.35. Management discusses operating trends, liquidity, and outlook in the quarterly filing.

  • Net income $18.4M.
  • Diluted EPS $0.35.
  • MD&A highlights operating priorities, liquidity, and sector-specific risks.

Headline financials

Total Revenue

$260M

Previous: $262M-1.0%
EPS (adj)

$0.35

Previous: $0.07+400.0%
Adjusted EBITDA

$26.6M

Previous: $25.3M+5.1%
Adjusted EBITDA Margin

10.2%

Previous: 9.6%+6.2%
Home Health Admissions

57.2K

Previous: 56.8K+0.7%
Hospice Admissions

3.3K

Previous: 3.0K+8.0%
Hospice Patient Days

342.8K

Previous: 308.5K+11.1%
Hospice Average Daily Census

3.8K

Previous: 3.4K+12.3%
Non-Medicare Admissions

33.2K

Previous: 30.9K+7.4%
Medicare Admissions

24.0K

Previous: 25.9K-7.3%
Cost per Patient Day

$27.90

No prior period
Capital Expenditures

-$300K

Previous: -$1.8M+83.3%
Free Cash Flow

$17.5M

No prior period
Net Income

$17.8M

Previous: $200K+8800.0%
Operating Income

$15.9M

Previous: $12.9M+23.3%
Gross Profit

-$130M

Previous: $128M-201.6%
Cash & Equivalents

$39.5M

No prior period
Total Assets

$1.24B

No prior period

Revenue & EPS history

Enhabit · Revenue · Quarterly

$260M

Q1 2025-1%vs Q1 2024
Beat estimate in 3 of 4 quarters(75%)
ActualEstimate

Revenue by segment

Enhabit · $261M total across 2 segments · Q4 2024

  • Home Health
    $210M
  • Hospice
    $51.1M

Forward guidance

The quarterly filing discusses operating priorities, capital allocation, and sector risks.

Tailwinds

  • MD&A outlines strategic priorities and liquidity.
  • Segment commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 14 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+1.9%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+8.6%

Avg return

30 days after

40%

6 / 15 earnings

Positive

+18.2%

Q1 2025

Best reaction

-6.1%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+0.1%
Q4 2025+0.0%+0.0%+2.9%
Q3 2025-6.1%-2.7%+13.6%
Q2 2025+15.2%+11.4%+15.1%
Q1 2025+18.2%+27.7%+31.7%
Q4 2024+1.6%+2.3%+13.3%
Q3 2024-0.4%-5.7%-12.0%
Q2 2024+0.0%-3.1%+14.8%
Q1 2024+0.0%-5.4%-13.4%
Q4 2022+0.0%-5.7%-0.4%
Q3 2023+6.1%+6.7%+19.3%
Q2 2023-2.6%-2.9%+5.6%
Q1 2023-4.5%-6.0%-2.0%
Q3 2022-0.1%+1.9%+11.3%
Q2 2022+1.7%+5.1%+20.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro